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Retinal and choroidal inflammatory lesions are important causes of visual loss, but the mechanisms 
regulating intraocular inflammation remain poorly understood. By virtue of its position at the 
blood-retina barrier, the retinal pigment epithelium (RPE) cells may be critical to the initiation and 
propagation of ocular inflammation. Previously we showed that cytoklne-stimulated RPE cells produce 
interleukin-8, a well-defined chemotactic factor for neutrophils and lymphocytes. In this study, we found 
that human RPE cells stimulated by human recombinant interleukin-1-P (rIL-1P) or tumor necrosis 
factor-a (rTNF-n) produce interleukin-6 (IL-6). Using a plasmacytoma proliferation assay, significant 
levels of IL-6 were found in media of RPE cells stimulated with either rIL-lb or rTNF-cr for 4 hr. 
Progressive accumulation of IL-6 in media overlying stimulated RPE cells occurred over the subsequent 
20 hr. IL-lp was a significantly more potent stimulator of RPE IL-6 production than TNF-a. RPE IL-6 
production in response to each of these cytokines was also dose-dependent over a range of 20 pg to 20 ng 
ml-‘. Specific anti IL-6 antibody, but not control immunoglobulin. neutralized RPE-derived IL-6 activity 
in the plasmacytoma proliferation assays. RPE IL-6 mRNA levels were detectable 1 hr after cytokine 
stimulation, plateaued within 8 hr in 24-hr assays, and demonstrated dose-dependent kinetics in 6 hr 
assays. Lipopolysaccharide failed to induce RPE IL-6 mRNA expression or RPE IL-6 production. Our 
findings indicate that RPE cells express IL-6 mRNA and secrete biologically active IL-6 when stimulated 
by inflammatory cytokines. RPE IL-6 secretion may be important in ocular lesions involving 
differentiation and activation of lymphocytes. 
Key words : retinal pigment epithelium : interleukin-6 : cytokines : interleukin- 1; tumor necrosis factor ; 
lipopolysaccharide. 
1. Introduction 
Leukocytic infiltration of the choroid, retina, and 
vitreous is an important pathogenetic feature of a wide 
spectrum of inflammatory, vascular, degenerative, 
and dystrophic diseases of the retina and choroid 
(Green, 1985), but the mechanisms important in 
eliciting and propagating intraocular inflammation 
remain largely unknown. The neuroectodermally- 
derived retinal pigment epithelium (RPE) consists of a 
monolayer of cells that is strategically located between 
choroidal blood circulation and the neurosensory 
retina. As part of the blood-retina barrier (Marmor 
and Zinn, 19 79), the RPE is positioned to interact with 
neural cells in the retina and leukocytes emerging 
from choroidal vessels, thereby enabling it to perform 
critical roles in the initiation and propagation of 
ocular inflammation. The identification of RPE Fc and 
C3bi receptors (Elner et al., 1981) and the expression 
of RPE HLA-DR antigens following interferon-y (IFN- 
y) stimulation and in retinal diseases (Detrlck et al., 
1985, 1986; Chan et al., 1986) imply roles for RPE 
cells in ocular inflammation. Active participation of 
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the RPE in the regulation of retinal and choroidal 
leukocyte infiltration is suggested by recent studies in 
which we have demonstrated that human RPE cells 
stimulated with human recombinant interleukin- l-/3 
@IL-@) or recombinant tumor necrosis factor-a (rTNF- 
a) produce interleukln-8 (IL-8) which is chemotactic 
for neutrophils and lymphocytes (Elner et al., 1990). 
In this study, we report that human RPE cells 
synthesize and secrete IL-6 when exposed to physio- 
logic concentrations of m-/3 or rTNF-a, inflammatory 
cytokines which are known to be secreted by leuko- 
cytes and tissue-based vascular endothelial cells, 
fibroblasts, astrocytes and Mueller cells (Roberge, Caspi 
and Nussenblatt, 1988; Akira et al., 1990). IL-6 
production by resident, neural-derived RPE cells in 
response to inflammatory cytokines may be important 
in the initiation and propagation of retinal and 
choroidal inflammations, involving recruitment, ac- 
tivation, and proliferation of T- and B-lymphocytes. 
2. Materials and Methods 
Human WE Cell Cultures 
Human RPE cells were isolated from donor eyes 
within 24 hr of death using a modification of the 
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method of Edwards (1982) as previously performed 
(Elner et al., 1990). In brief, the sensory retina was 
gently separated from the RPE monolayers which was 
then trypsinized (0.25 %) for 3040 min from Bruch’s 
membrane into serum-free DMEM containing 0.02 mg 
ml-’ DNase I (Sigma Chemical Co., St Louis, MO). 
Following centrifugation and resuspension in Dul- 
becco’s Modified Essential Medium (DMEM) containing 
15 % fetal bovine serum, penicillin G (100 U ml-‘), 
streptomycin sulfate (100 ,ug ml-l), and amphotericin 
B (2.5 pug ml-l) (Gibco Inc., Grand Island, NY), the RPE 
cells were seeded into 25cm2 Falcon Primaria flasks 
(Becton-Dickinson Inc., Lincoln Park, NJ) to inhibit 
fibroblast growth. Cells were passaged by trypsin- 
ization, and plating at 5 x lo5 RPE cells per flask 
resulting in near confluent (> 90%: about 1.5 x lo6 
RPE cells per flask) cultures in 5-7 days. In confluent 
cultures, each of the three RPE cell lines used displayed 
distinctive morphologic features typical for RPE cells, 
including growth in monolayers composed of poly- 
gonal cells. 
To exclude the possibility of contaminating cell 
types, RPE cultures were examined using various 
markers. The RPE monolayers exhibited uniform 
immunohistochemical staining for fibronectin, lam- 
inin, and type IV collagen in a chickenwire dis- 
tribution, characteristic for these epithelial cells 
(Campochiaro, Jerdan and Glaser, 1986). The RPE 
cells also avidly and uniformly incorporated both 
fluorescently-labeled native and acetylated low density 
lipoproteins (Elner, Davis and Elner, 1984; Elner, 
1986) in contrast to fibroblasts which do not bind or 
internalize acetylated low density lipoproteins. The 
RPE cells also failed to stain for factor VIII antigen or 
with Ulex europaeus I lectin (Vector Laboratories, 
Burlingame, CA), markers for vascular endothelial 
cells. Furthermore, sister cultures of the RPE cells used 
in our IL-6 studies produced IL-8 (neutrophil chemo- 
tactic factor) when exposed to r&1/3 and rTNF-a, but 
failed to do so in response to LPS (Elner et al., 1990) 
that induced IL-8 under the same experimental 
conditions in vascular endothelial cells (Strieter et al., 
1989) and mononuclear phagocytes (Strieter et al., 
1990). Taken together, these studies indicate that our 
RPE cell cultures were pure and uniform and that the 
results obtained could not be due to contaminating 
cell types such as macrophages, vascular endothelium, 
or fibroblasts. 
RPE Cell Stimulation with rlL-1 p, rTNF-a, and LPS 
In all experiments, simultaneous, parallel assays 
were performed on fourth-passaged RPE cells in 25 
cm2 sister flasks containing near confluent cells seeded 
at the same time and density from the same parent 
cultures. Assayed RPE cells were either unstimulated 
or treated with human recombinant (r)IL-l/3 (Upjohn 
Co., Kalamazoo, MI), human rTNF-a (Cetus Corp., 
Emeryville, CA), or lipopolysaccharide (LPS : Escher- 
ichia coli 0111: B4 ; Sigma). The specific activities of 
rIL-lp and rTNF-a were 30 and 20 IJ ng-‘, respect- 
ively. 
Prior to stimulation with human cytokines or LPS, 
RPE cell cultures were rinsed and placed in fresh, 
serum-free medium. Assays were begun by overlaying 
RPE cultures with either 2 ml of serum-free medium 
(unstimulated control) or 2 ml of medium containing 
the appropriate amount of r&1,0, rTNF-n, or LPS. To 
determine time-dependent induction of RPE IL-6, RPE 
cultures were exposed to IL-1B (20 ng ml-‘), TNF-c~ 
(20 ng ml-‘), or LPS (10 ,ug ml-‘) for 1, 2, 4, 8 and 
24 hr. To determine dose-dependent induction of RPE 
IL-6, RPE cultures were exposed to various con- 
centrations of IL-lp and TNF-a (20 pg ml-’ to 
20 ng ml-‘) and LPS (10 pg ml-’ to 10 yg ml-‘) in 6-hr 
assays. Following experimental incubations, con- 
ditioned media (CM) were collected, centrifuged to 
remove particulates, and stored at - 70°C until 
bioassays for IL-6 protein were performed. 
RPE Cell IL-6 mRNA Analysis 
Total RPE cell RNA was extracted as previously 
described (Elner et al., 1990). In brief, the adherent 
RPE cells were solubilized in 25 mM Tris, pH 8.0, 
containing 4.2 M guanidine isothiocyanate, 9.5 % 
Sarkosyl, and 0.1 M /3-mercaptoethanol. An equal 
volume of 100 mM Tris, pH 8.0, containing 1.0% SDS 
and 10 mM EDTA was then added and the RNA 
extracted with chloroform-phenol. The alcohol-pre- 
cipitated RNA was separated by formaldehyde/l % 
agarose gels and transblotted to nitrocellulose. The 
baked blots were prehybridized and then hybridized 
with a “P-5-end-labeled 30-mer oligonucleotide probe 
complementary to nucleotides of the published cDNA 
sequence for human IL-6 (May, Helfgott and Sehgal, 
1986). The sequence of the probe was S’-GGT- 
GAG-TGG-CTG-TCT-GTG-TGG-GGC-GGC-TAC-3’. The 
probe was 5’-end labeled with [3zP]adenosine 5’- 
triphosphate (ICN Biomedical& Inc., Costa Mesa, CA). 
Extracted RNA was separated by electrophoresis, 
transferred to nitrocellulose, hybridized with the 32P- 
labeled probes, and washed in 6 x standard saline 
citrate (SSC) and 0.5 % sodium pyrophosphate at 
57’C for 1 hr. The blots were autoradiographed and 
quantitated by laser densitometry. Equivalent 
amounts of total RNA loaded per gel lane were 
assessed by monitoring 28 s and 18 s rRNA. 
IL-6 Bioassay 
IL-6 levels in RPE cell CM were measured using an 
extremely specific and sensitive plasmacytoma pro- 
liferation assay (Aarden, Lansdorp and de Groot, 
198 5 ; Van Snick, 1990) involving the IL-6 dependent 
murine hybridoma cell line B13.29, clone B9 (kindly 
provided by J. Gauldie, McMaster University, Hamil- 
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FIG. 1. Time-dependent JL6 bioactivity in RPE cell conditioned media (CM) after &l/3 (W), TNF-a (n), and LPS (A) RPE 
cell stimulation. Human RPE cells were exposed to IL-lp (20 ng ml-l), TNF-or (20 ng ml-l) or LPS (10 pg ml-‘) at 3 7°C for the 
times indicated. The CM were removed and their IL-6 bioactivities measured using a standardized, calorimetric plasmacytoma 
proliferation assay as described in Materials and Methods. Each value represents the mean of assays performed on separate flasks 
of RPE cells + S.D. CM from WE cells stimulated for 24 hr with LPS did not contain significantly more activity than media 
conditioned by unstimulated RPE cells for 24 hr (*). 
ton, Ontario) as previously described (Aarden et al., 
198 7). Briefly, serial dilutions of test samples were 
incubated with 100 ~1 of IL-6 dependent plasma- 
cytoma cells at a concentration of 5 x lo4 cells ml-l for 
72 hr in a humidified incubator at 37°C and 5% CO,. 
Proliferation was measured in a calorimetric assay 
using 3-(4,5-dimethylthiiazol-2-yl)-2,5 diphenyltetra- 
zolium bromide (MTT; Sigma). During the final 6 hr of 
the plasmacytoma assay, 20 ~1 of MYIT (5 mg ml-l in 
PBS) was added to each sample. The CM were then 
aspirated and 100 ,ul of isopropanol acidified with 
004 M HCl (3.4 ~1 ml-’ isopropanol) was added. 
Absorbance at 550 nm was then measured. Serial 
dilutions human rIL-6 (R&D Systems Inc.. Minne- 
apolis, MN) were used to generate a standard curve 
for each assay. IL-6 concentrations in experimental 
samples were calculated using the standard curves. 
Prior to assays on some CM from RPE cells 
stimulated with human rIL-lp, aliquots of the samples 
were pre-incubated with non-immune goat serum or 
with goat-anti-human m-6 IgG antibody (R&D 
Systems ; 2 ,ug ml-‘). We found the neutralizing anti- 
rIL-6 antibody to stoichiometrically-inhibit human 
m-6 (R&D Systems) activity in our plasmacytoma 
bioactivity assay and to stoichiometrically-bind m-6, 
but fail to bind r&l,& rTNF-a, or LPS, in ELISA assays 
performed according to the method of Ceska et al. 
(1989). 
Statistical Analysis 
Three complete and separate experiments, each 
performed on a different RPE cell line, were carried out 
using three flasks of RPE cells for each assay condition. 
All IL-6 bioassays and ELISA assays on RPE cell CM 
were performed in triplicate. Data from all experiments 
were pooled and are expressed as mean pg IL-6 If: S.D. 
The various groups were compared using Student’s t- 
test and P < 001 were considered to be statistically 
significant. 
3. Results 
Time-dependence of RPE IL-6 Production Induced by 
IL-P or TNF-ct 
Significant levels of IL-6 bioactivity were detected in 
conditioned media (CM) overlying human RPE cells 
within 4 hr of IL-lp (20 ng ml-l) or TNF-a (20 ng 
ml-l) stimulation. Following initial rapid rises in IL-6 
bioactivity activity over 8 hr, more gradual increases 
were observed in CM from cytokine-stimulated RPE 
cells over the next 16 hr (Fig. 1). The high levels of 
RPE IL-6 induced by el/3 at 8 and 24 hr were 
significantly greater than those resulting from TNF-a 
stimulation. At each time point, IL-l/3 or TNF-cx 
exposure resulted in significantly greater levels of IL-6 
bioactivity than LPS. Moreover, LPS failed to induce 
RPE IL-6 production. Accordingly, 24-hr CM from 
RPE cells stimulated with LPS did not contain 
significantly more IL-6 activity (229 f 48 pg ml-‘) 
than the low levels found in 24-hr CM from 
unstimulated RPE cells (2 33 + 101 pg ml-l). LPS also 
did not induce significant RPE IL-6 in 6-hr dose- 
response assays (vide infra). Peak IL-6 biological 
activities in the RPE cell CM were found at 24 hr, 
presumably from accumulating IL-6 protein corre- 
sponding to continued IL-6 mRNA induction. 
To insure that the IL-6 bioactivity measured was 
actual IL-6 protein, IL-6 bioactivity in CM from RPE 
cell cultures exposed to IL-lp was neutralized with 
specific goat-anti-human rIL-6 antibody (R&D Sys- 
tems). Preincubation with the anti-IL-6 antibody (2 pg 
ml-l) significantly reduced measurable IL-6 bioactivity 
in the CM of RPE cells IL-l/3 (Table I). Under the same 
conditions. non-immune goat serum did not reduce 
measurable IL-6 activity in CM from RPE cultures 
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TABLE I 
Neutralization oflL-6 bioactivity in human RPE cell conditioned media (CM) 
IL-6 ( lo3 pg ml-’ per lo6 cells) * s.o. 
RPE stimulation CM 
CM + normal 
goat serum 
CM + goat-anti-IL-6 
(2 pug ml-‘) 
IL-lfi (20 ng ml-‘) 
(24 hr) 
IL-lb (2 ng ml-‘) 
(8 W 
75.65 2 7.09 83.141-6.71 0.99 kO.53 
12.93 f 5.57 10.57k6.79 0.53 kO.12 
(Al 
I 
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FIG. 2. Time-dependent induction of RPE IL-6 mRNA expression by IL-l/X TNF-a, and LPS. Human RPE cells were exposed 
to IL-lp (20 ng ml-‘), TNF-a (20 ng ml-l), or LPS (10 ,ug ml-l) at 37’C for the times indicated. The media were removed and 
total cellular RNA was extracted and evaluated by Northern blot analysis for IL-6 mRNA. A, Twelve-hour autoradiograph of 
Northern blot analysis of IL-6 mRNA from RPE ceils treated with either IL-l,& TNF-a, or LPS, respectively: B, relative density 
of IL-6 mRNA signals determined by laser densitometry ; C, 18 and 28 s rRNA of the same blots. IL-6 mRNA was not detected 
in unstimulated-WE cultures assayed for 24 hr. 
exposed to the same concentrations of IL-l/ No 
detectable IL-6 bioactivity was present in uncondi- 
tioned media containing IL-l& TNF-a, or LPS. 
Time-dependence of RPE IL-6 mRNA Expression 
Induced by IL-1 p or TNF-a 
Northern blots showed increases in steady state RPE 
IL-6 mRNA expression 1 hr after RPE cell exposure to 
IL-l/3 (20 ng ml-‘) or TNF-a (20 ng ml-l) (Fig. 2). 
Time-dependent increases in RPE IL-6 mRNA were 
observed in RPE cells exposed to IL-l/3 or TNF-a with 
peak steady state IL-6 mRNA expression occurring at 
8 hr for both cytokmes. At each time point, IL-lp was 
substantially more potent in inducing IL-6 mRNA 
than TNF-or. In contrast, LPS (10 pg ml-‘) did not 
induce RPE IL-6 mRNA after 24 hr indicating that the 
higher levels obtained with IL-lb and ‘I’NF-cr were 
specific. IL-6 mRNA was not detected in unstimulated 
RPE cells. RPE cell IL-6 mRNA migration on the 
Northern blots was identical to that reported for IL-6 
derived from other sources (Kishimoto, 1989 ; Cicco 
et al., 1990; Elias and Len% 1990; Kasahara et al., 
1990). 
Dose-dependence of RPE IL-6 Production Induced by IL- 
1 p or TNF-a 
Both TNF-ol and IL-l/3 elicited progressive and 
statistically-significant increases in IL-6 bioactivity 
over a dose range of 20 pg ml-l to 20 ng ml-’ in 6-hr 
bioassays (Fig. 3). Within this wide physiologic range 
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FIG. 3. Dose-dependent IL-6 bioactivity in RPE cell conditioned media (CM) after IL-lb, TNF-a, or LPS stimulation. Human 
RPE cells were exposed to IL-l/I, TN&z, or LPS at the concentrations indicated for 6 hr at 37°C. The CM were removed and 
their IL-6 bioactivities measured using a standardized, calorimetric plasmacytoma proliferation assay as described in Materials 
and Methods. Each value represents the mean of assays performed on separate flasks of RPE cells k S.D. Supernatants from RPE 
cells stimulated with LPS (10 pg ml-l) did not contain significantly more activity than media conditioned by unstimulated RPE 
cells. 
for IL-l/3 and TNF-a, maximal IL-6 bioactivity was 
found in CM of RPE cells exposed to cytokine 
concentrations of 20 ng ml-’ with 50% of the maxi- 
mal activity occurred occurring between 0.2 and 
2.0 ng ml-‘. For any given dose, IL-l/I was sig- 
nificantly more potent and induced approximately ten 
times more RPE IL-6 production than TNF-a. LPS 
failed to stimulate significant levels of RPE IL-6 
(47 + 3 pg ml-l) which were virtually absent in media 
from unstimulated RPE cultures (39 f 6 pg ml-l). 
Media alone or media containing TNF-a, IL-l/3. or LPS 
did not contain measurable IL-6 in our bioassays. 
Dose-deperzdence of RPE IL-6 mRNA Expression 
Induced by IL-lp or TN&I 
Steady state IL-6 gene expression following TNF-a 
(data not shown) and IL-lp stimulation for 6 hr was 
also concentration-dependent (Fig. 4). IL-6 mRNA 
expression was maximal at an IL-lb concentration of 
20 ng ml-’ and was detectable at 20 pg ml-‘. Fifty 
percent of the maximal response occurred between 0.2 
and 2 ng ml-’ of IL-l,& IL-6 mRNA was not detected 
in unstimulated RPE cells. 
4. Discussion 
Human IL-6 is a 21-28 kDa multifunctional cyto- 
kine that induces numerous physiologic and immune 
responses (Kishimoto, 1989; Le and Vilcek, 1989: 
Van Snick, 1990). Although not constitutively pro- 
duced by normal cells, several cell types including 
neutrophils, lymphocytes, monocytes, and tissue- 
based cells such as vascular endothelial cells, fibro- 
blasts and astrocytes elaborate IL-6 upon exposure to 
LPS or cytokines including IL- l/I and TNF-a (Jirik et al., 
1989 ; Kishimoto, 1989 ; Le and Vilcek, 1989 : Sironi 
et al., 1989: Cicco et al., 1990; Kasahara et al., 1990; 
Van Snick, 1990). The principal roles of IL-6 include 
the induction of terminal B-lymphocyte differentiation 
(Kishimoto and Hirano, 1988), stimulation of 
immunoglobulin production by plasma cells (Kishi- 
moto, 1987; Kishiioto and Hirano, 1988), and 
promotion of T-lymphocyte proliferation, activation, 
and cytolytic responses (Lotz et al., 1988 ; Van Snick, 
1990). Whereas B-lymphocyte responses to IL-6 are 
synergized by, but not dependent on IL-lp (Vink et al., 
1986), IL-6 effects on T-lymphocytes are principally 
due to enhanced responsiveness to IL-2, which itself is 
induced by IL-lb, mainly during the initial stages of T- 
lymphocyte proliferation and activation (Le and Vilcek. 
1989: Van Snick, 1990). 
Our results show that RPE cells produce IL-6 in a 
time- and dose-dependent manner when stimulated by 
human rIL-1P and rTNF-a (Figs 1 and 3) and 
corroborate those recently presented by Planck et al. 
(1990) who independently found RPE IL-6 production 
in response to IL-lp. Our results also demonstrate that 
cultured human RPE cells produce steady-state IL-6 
mRNA (Figs 2 and 4) and levels of biologically active 
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FIG. 4. Progressive RPE IL-6 mRNA expression induced by 
increasing physiologic concentrations of ILl/X Human RPE 
cells were exposed to the IL-lp concentrations indicated for 
6 hr at 37’C. The media were removed and total cellular 
RNA was extracted and evaluated by Northern blot analysis 
for IL-6 mRNA. A, Northern blot analysis of mRNA from 
cells stimulated with increasing doses of IL-l/3 and probed 
for IL-6 mRNA : B, relative density of the signals determined 
by laser densitometry : C, 18 and 28 s t-RNA of the same 
blots. 
IL-6 similar to those elaborated by vascular endothelial 
cells, fibroblasts, and monocytes when exposed to 
physiologic concentrations of IL- I,& (Kishimoto, 19 8 9 ; 
Le and Vilcek, 1989; Van Snick, 1990). IL-6 mRNA 
induction and protein secretion are induced over wide 
physiologic ranges of r&lb and rTNF-a concen- 
trations and are not due to LPS contamination. 
Half-maximal effects of IL-6 on normal B-lympho- 
cytes are observed at approximately 2 ng ml-’ (Van 
Snick, 1990), a concentration which we regularly 
observed in RPE cell CM following IL-lp and TNF-ol 
stimulation. 
The RPE and the retinal vascular endothelium form 
the blood-retina barrier (Marmor and Zlnn, 1979). 
Due to their strategic position in the eye, both cell 
types are involved in numerous pathologic processes 
and influence the interactions between circulating 
leukocytes and the retina (Green, 198 5). The RPE and 
vascular endothelium share several features which 
may be important in their physiologic and pathologic 
roles. For example, cytokine-stimulated endothelial 
cells express surface histocompatibility antigens (Col- 
lins et al., 1986) and neutrophil adherence proteins 
(Gamble et al., 1985) and produce biologically-active 
arachidonic acid metabolites (Kawakami et al., 1986), 
tissue factor (Bevilacqua et al., 1986), and platelet- 
derived growth factor (Hajjar et al., 1987). RPE cells 
also express histocompatibility antigens (Detrick et al., 
1985, 1986; Chan et al., 1986) and leukocyte ad- 
herence proteins (Pavilack et al., 1990), contain high 
levels of arachidonic acid (Anderson et al., 1976). 
induce vascular endothelial procoagulant activity 
(Glaser, 1989), and produce growth factors, in- 
cluding platelet-derived growth factor-like proteins 
(Campochiaro et al., 1989). Recently, we reported 
that RPE cells, like vascular endothelial cells, respond 
to IL-lp and TNF-a: by producing neutrophil chemo- 
tactic factor (Elner et al., 1990), now designated 
interleukin-8 (IL-8), that is also chemotactic for 
lymphocytes at low concentrations (Larsen et al., 
1989). This study extends the known similarities 
between RPE cells and vascular endothelial cells by 
showing that RPE cells produce biologically active IL-6 
in response to physiologic doses of IL-lp and TNF-a. 
Although we have not studied RPE cytokine produc- 
tion in intact retinal tissue, our findings on cultured 
RPE cells lead to the contention that cytokine- 
stimulated RPE cells might elicit diapedesis of lympho- 
cytes into injured or inflamed vitreous, retinal, and 
choroidal tissue by secreting IL-8 (Elner et al., 1990). 
Concurrent RPE IL-6 secretion may then induce 
lymphocytic proliferation, B-lymphocyte maturation, 
and immunoglobulin production as well as T-lympho- 
cyte activation and cytotoxic activity within the eye. 
The elaboration of IL-6 by vascular endothelial and 
RPE cells at the blood-retina barrier emphasizes that 
these critically-positioned, tissue-based cells may 
not be passive targets for injury, but may actively 
participate in ocular inflammatory and immunologic 
diseases. 
Pathologic RPE cell alterations, including HLA-DR 
antigen expression, are thought to be important in a 
variety of vascular, inflammatory, degenerative, and 
dystrophic diseases of the retina and choroid (Marmor 
and Zinn, 1979; Green, 1985; Detrick et al., 1985, 
1986; Chan et al., 1986). Inflammatory cells, vascular 
endothelial cells, fibroblasts, astrocytes, and Muller 
cells which also actively participate in these diseases 
are known producers of IL-l/3 and TNF-a (Roberge 
et al., 1988; Akira et al., 1990; Hofman and Hinton, 
1990) and might thereby induce local RPE IL-6 
production in vivo in a manner similar to that observed 
in vitro. RPE-derived IL-6 may be of particular 
importance in uveal and retinal inflammatory diseases 
in which lymphocytes are key participants, including 
sympathetic ophthalmia, Vogt-Koyanagi-Harada syn- 
drome, and experimental autoimmune uveitis, all of 
which are thought to involve cell mediated immunity 
to endogenous antigens present within the eye 
(Lightman and Chan, 1990). Thus, local production of 
IL-6 by RPE cells may enhance lymphocyte pro- 
liferation and immune responses in experimental 
uveitis induced by IL-lfi, TNF-cc, or LPS (Rosenbaum 
et al., 1987, 1988) and experimental lens-induced 
uveitis in which high choroidal levels of IL-l and TNF 
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are found (Attalla, Linker-Israeli and Rao, 1989). The 
effects of RPE IL-6 on infiltrating lymphocytes in 
uveitis may be further augmented by ambient intra- 
ocular IL-l/? and TNF-cr. levels responsible for inducing 
RPE IL-6 production and intraocular IL-2 in uveitis 
(Hooks, Chan and Detrick, 1988). In fact, high levels 
of locally-produced IL-6 have been found in ex- 
perimental endotoxin-induced uveitis (Hoekzema et 
al., 1991) as well as in the aqueous humor of patients 
with Fuchs’ heterochromic iridocyclitis and toxo- 
plasma uveitis (Murray et al., 1990) suggesting that 
IL-4 may be important in the pathogenesis of clinical 
ocular inflammatory disease. 
Apart from its effects on immune responses, IL-6 
provides trophic stimuli for neural cells by inducing 
and maintaining nerve growth factor secretion by 
astrocytes (Frei et al., 1989) and the differentiation of 
pheochromocytoma cells lines (Satoh et al., 1988) and 
cerebral cortical neurons (Hama et al., 1989). It is 
possible that similar IL-6 stimuli may be important in 
sensory retina development, maintenance, and repair. 
The capacity of IL-6 to elicit macrophage-like mor- 
phology, increased phagocytic activity, and increased 
expression of Fc and C3 receptors on myeloid cells 
(Miyaura et al., 1988) may likewise be important as 
an autocrine stimulus to RPE expression of these 
features during inflammation and repair. 
Identification of RPE-derived cytokines such as IL-6 
illuminates important mechanisms through which 
resident, neural-derived phagocytic RPE cells may 
participate in ocular physiology and disease. 
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